Equities

MedMira Inc

MedMira Inc

Actions
  • Price (EUR)0.046
  • Today's Change0.00 / 0.00%
  • Shares traded330.00k
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year MedMira Inc's revenues fell -54.57% from 952.13k to 432.53k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 1.83m to a larger loss of 2.68m.
Gross margin62.61%
Net profit margin-812.38%
Operating margin-525.29%
Return on assets-61.10%
Return on equity--
Return on investment--
More ▼

Cash flow in CADView more

In 2023, cash reserves at MedMira Inc fell by 20.28k. Cash Flow from Financing totalled 1.25m or 288.70% of revenues. In addition the company used 1.27m for operations while cash used for investing totalled 1.27k.
Cash flow per share-0.0041
Price/Cash flow per share--
Book value per share-0.024
Tangible book value per share-0.024
More ▼

Balance sheet in CADView more

MedMira Inc uses little or no debt in its capital structure.
Current ratio0.2212
Quick ratio0.2112
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.